ROCKVILLE, Md. and BEIJING, Sept. 11,
2020 /PRNewswire/ -- CASI Pharmaceuticals, Inc.
(Nasdaq: CASI), a U.S. biopharmaceutical company focused on
developing and commercializing innovative therapeutics and
pharmaceutical products, announced that Dr. Wei-Wu He, Chairman and Chief Executive Officer
of CASI Pharmaceuticals, will be presenting at the following
upcoming virtual conferences in September. Details for the virtual
conferences are as follows.
H.C. Wainwright 22nd Annual Global Investment
Conference
Date: Monday, September
14th
Time: 12:30 PM (EDT)
Oppenheimer Fall Healthcare Life Sciences & MedTech
Summit
Date: Wednesday, September
23rd
Time: 1:40 PM
(EDT)
Webcast or external link of the company presentations will be
available under "Events & Presentations" in the "Investors
Relations" section of CASI's website. Archived replays will be
available for approximately 90 days following the event.
About CASI Pharmaceuticals
CASI Pharmaceuticals, Inc. ("CASI" or the "Company") is a U.S.
biopharmaceutical company focused on developing and commercializing
innovative therapeutics and pharmaceutical products in China, the United
States, and throughout the world. The Company is focused on
acquiring, developing and commercializing products that augment its
hematology oncology therapeutic focus as well as other areas of
unmet medical need. The Company intends to execute its plan to
become a leader by launching medicines in the greater China market leveraging the Company's
China-based regulatory and
commercial competencies and its global drug development expertise.
The Company's operations in China
are conducted through its wholly-owned subsidiary, CASI
Pharmaceuticals (China) Co., Ltd.
("CASI China"), which is located in Beijing, China. The Company has built a
commercial team of over 70 hematology and oncology sales and
marketing specialists based in China. More information on CASI is available
at www.casipharmaceuticals.com.
COMPANY
CONTACT:
CASI
Pharmaceuticals, Inc.
240.864.2643
ir@casipharmaceuticals.com
|
INVESTOR
CONTACT:
Solebury
Trout
Jennifer
Porcelli
646.378.2962
jporcelli@troutgroup.com
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/casi-pharmaceuticals-inc-to-participate-in-two-upcoming-september-conferences-301128032.html
SOURCE CASI Pharmaceuticals, Inc.